Searchable abstracts of presentations at key conferences in endocrinology

ea0086en7.2 | Endocrine Consequences of Living With and Beyond Cancer | SFEBES2022

Incidence of endocrine deficits after management of brain tumours

Murray Robert

The adverse effect of childhood cancer and treatment thereof on growth was firmly established in the mid-1970’s. The impact on growth is multifactorial, however, cranial irradiation was quickly established as one of the most important contributors. Exposure of the hypothalamo-pituitary (HP) region to radiation in childhood cancer survivors is now a well-established risk factor for the development of anterior hypopituitarism. The degree of hypopituitarism can vary between ...

ea0066cme3.1 | Session 3 | BSPED2019

Challenges in the management of the SGA child

Murray Phil

Approximately 650 000 children born in the UK each year, using a definition of a birth weight less than 2 S.D. 14 950 children are born SGA. 90% of these children will experience catch up growth by the age of 4 years leaving around 1500 children eligible for treatment with recombinant human growth hormone. Data from the BSPED audit in 2016 recorded 177 children started on GH at a mean age of 6.2 years – all of these children will have been short at 4 years ...

ea0021sig2.2 | Pituitary Special Interest Group Session | SFEBES2009

Diagnostic difficulties of GH deficiency

Murray R

In adults, the absence of a biological marker equivalent to height in children, means the diagnosis of GHD relies exclusively on biochemical tests. Confirmation of GHD when suspected involves use of GH stimulation tests, serum levels of GH-dependent peptides, and 24 h GH profiles.GH stimulation tests have become the mainstay for diagnosis of adult GHD, which superficially appears to be relatively simple. GHD in the adult is accepted as a peak GH response...

ea0082wa4 | Workshop A: Disorders of the hypothalamus and pituitary | SFEEU2022

Non-functioning pituitary adenoma with high Ki 67 10%

Rasool Irum , Murray Robert

A 54 year old gentleman presented to the eye services with reduced vision on the right attributed to a cataract. Following cataract surgery there was no improvement and his vision declined further with reducing vision also on the left. He was reviewed in Neuro-ophthalmology clinic 29/10/21 and clinical suspicion of a pituitary lesion based on binasal retinal ganglion cell layer loss and bilateral optic atrophy prompted urgent imaging. His right eye visual acuity was to hand mo...

ea0031p130 | Clinical practice/governance and case reports | SFEBES2013

Radioactive iodine-induced hyperparathyroidism

Shankaran Vani , Murray Robert

Case history: A 27 years old lady having presented with a neck mass, underwent a total thyroidectomy for thyroid malignancy in 1967. Histology confirmed papillary carcinoma of the thyroid. In 1968, she complained of tiredness and mild neck swelling despite TSH suppressive therapy. Her thyroid uptake study showed a residuum of thyroid tissue within the neck. She went on to have radioiodine ablation therapy on two separate occasions. She responded well with no evidence of residu...

ea0025p219 | Nursing practise | SFEBES2011

Low bone mass is an infrequent long-term sequelea of pituitary disease

Lynch Julie , Murray Robert

Introduction: Within the setting of putative or established pituitary disease the primary disease process (i.e. Cushing’s disease), hormone deficits (i.e. sex steroids, GH), and inappropriate replacement therapy (i.e. glucocorticoids) are reputed to predispose to low bone mass.Patients and Methods: We examined bone mass at the lumbar spine (LS) and total hip (TH) using DXA in 259 patients with an insult to the hypothalamo–pituitary axis (51.6&#...

ea0031p24 | Bone | SFEBES2013

Effect of bone mineral density in patients with non-functioning pituitary adenoma

Min Aye Aye , Murray Robert

We look into total 67 patients with non-functioning pituitary adenoma and review their bone mineral density in association with age and gender, effect of radiotherapy and hormonal replacement.Age range: 5.97% (4 patients) are between 18 and 40 years, 43.28% (29 patient) between 41 and 60 years and 50.74% (34 patients) are between 61 and 86 years.Gender: 61.19% (41 patients) are male and 38.8% (26 patients) are female.<p class="...

ea0028p344 | Thyroid | SFEBES2012

Second course of anti-thyroid treatment may be suitable for some individuals with relapsed Graves’ disease.

Kyaw Tun Julie , Murray Robert

Background: Graves’ disease is widely treated with anti-thyroid medication. After an initial course of treatment, remission is achieved in around 50% of patients. Definitive treatment is generally offered in relapsed cases, based on the assumption that remission rates following a second course of anti-thyroid medication are significantly lower.Method: A database of patients with Graves’ disease has been kept from 2004. 150 patients were suitabl...

ea0051p067 | Diabetes | BSPED2017

Siblings with monogenetic ABCC8 diabetes – phenotypic variability and implications

Jackson Charlotte , Bain Murray , Wei Christina

Introduction: ABCC8 gene mutations cause transient and permanent forms of neonatal diabetes with variable modes of inheritance. Almost all patients present with diabetes under 6 months old with rare cases upto 12 months. We report 2 siblings with diabetes and identical homozygous mutations of the ABCC8 gene, one of whom presented classically under 6 months old and the other unusually at 3 years of age.Cases: The index case, a British Pakistani f...

ea0051p070 | Diabetes | BSPED2017

Does maximising the use of bolus calculator glucose meters improves glycaemic control in children and adolescents with type 1 diabetes?

Rutherford Fiona , Bain Murray , Wei Christina

Introduction: Bolus calculator glucose meters (BCGM) facilitate self-management of patients with type 1 diabetes (T1DM). However, their effectiveness is dependent on the accuracy of the data entered, use of their smart functions and adherence to the insulin dosages advised. This study investigates whether optimising the use of BCGM is associated with better glycaemic control in children and adolescents with T1DM, and obstacles to preventing their effective use.<p class="ab...